Gastroenteritis Testing Market 2025: The Critical Role of Rising Incidence Of Bacterial Infections Drives Growth In The Gastroenteritis Testing Market Driver in Industry Evolution
The gastroenteritis testing market size is expected to see strong growth in the next few years. It will grow to $5.26 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to the rising prevalence of waterborne diseases, the growing number of healthcare facilities, the increasing use of point-of-care testing kits, the rising incidence of viral infections, and the increasing prevalence of gastrointestinal infections. Major trends in the forecast period include technological advancements, the adoption of molecular diagnostics, the integration of AI, point-of-care testing, and telemedicine.
Get Your Free Sample of The Global Gastroenteritis Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20556&type=smp
What have been the primary factors driving the gastroenteritis testing market’s growth?
The rising incidence of bacterial infections is expected to propel the growth of the gastroenteritis testing market going forward. Bacterial infections are rising due to increased antibiotic resistance, higher population density, and greater global travel, which facilitate the spread of resistant bacteria. Gastroenteritis testing is required for bacterial infections to accurately identify the specific pathogen-causing symptoms, such as diarrhea and vomiting, which informs appropriate treatment and prevents the spread of infection. For instance, in February 2024, according to the European Centre for Disease Prevention and Control, a Sweden-based government agency, 4,149 confirmed cases of shigellosis were reported across 30 EU countries in 2022, with 48% of those cases linked to travel. Therefore, the rising incidence of bacterial infections is driving the growth of the gastroenteritis testing market.
What are the key segments within the gastroenteritis testing market?
The gastroenteritis testing market covered in this report is segmented –
1) By Type: Viral Gastrointestinal Infections, Bacterial Gastrointestinal Infections, Parasitic Gastrointestinal Infections
2) By Disease Strains: Bacterial Strains, Viral Strains, Parasitic Strains
3) By Testing Methods: Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing
4) By End-User: Hospitals, Clinics Or Medical Centers, Research Institutes, Diagnostic Laboratories
Subsegments:
1) By Viral Gastrointestinal Infections: Norovirus, Rotavirus, Astrovirus, Adenovirus, Sapovirus
2) By Bacterial Gastrointestinal Infections: Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, Clostridium perfringens
3) By Parasitic Gastrointestinal Infections: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, Strongyloides stercoralis
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/gastroenteritis-testing-global-market-report
Which key players are shaping the gastroenteritis testing market?
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation
How will emerging trends drive the gastroenteritis testing market throughout the forecast period?
Major companies operating in the gastroenteritis testing market are developing innovative products, such as molecular gastrointestinal tests, to offer high sensitivity and specificity. A molecular gastrointestinal test is a diagnostic method that uses molecular techniques, such as polymerase chain reaction (PCR), to detect and identify specific genetic material from pathogens or organisms in gastrointestinal samples. For instance, in June 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies, launched the QIAstat-Dx Gastrointestinal Panel 2. This panel is notable for its ability to rapidly and comprehensively detect up to 16 clinically relevant bacterial, viral, and parasitic pathogens responsible for most gastrointestinal infections. It utilizes real-time polymerase chain reaction (PCR) technology to amplify multiple genetic targets in a single reaction, which is a significant improvement over traditional microbiological methods that typically require 24 hours to 10 days for sample incubation.
How do regional factors impact the gastroenteritis testing market, and which region is the largest contributor?
North America was the largest region in the gastroenteritis testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Gastroenteritis Testing Market Report 2025 Offer?
The gastroenteritis testing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Gastroenteritis testing involves a series of diagnostic procedures used to identify the cause of gastroenteritis, which is inflammation of the stomach and intestines. This condition is often caused by viral, bacterial, or parasitic infections and can lead to symptoms such as diarrhea, vomiting, abdominal pain, and fever. These tests help clinicians determine the cause of gastroenteritis and guide appropriate treatment, which may include antibiotics, antivirals, or supportive care such as hydration and rest.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20556
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment